In Group-17/18, insulin therapy was significantly less often initiated (33%), which may have indicated higher glycemic levels in the third trimester of pregnancy and an increased risk of neonatal hypoglycemia [18,19]. The gene discussed is INS; the disease is Hypoglycemia.